CHF
<乌鸦传媒 class="page-description">More in CHF
Biomarker of wine consumption believed to reduce misclassification and bias in study
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
Case-control study reinforces connection between inflammation and HFpEF
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
Another pricey TTR stabilizer to hit shelves
Standard of care prevails in single-center trial
More patients taking sodium zirconium cyclosilicate achieved normokalemia vs placebo recipients
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
Time for "long goodbye" to the "burning red devil," say editorialists
Recent developments of interest in cardiovascular medicine
Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts
